Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

32.43
Delayed Data
As of Apr 29
 -0.91 / -2.73%
Today’s Change
29.20
Today|||52-Week Range
43.85
+0.59%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close33.34
Today’s open33.15
Day’s range32.18 - 33.35
Volume406,984
Average volume (3 months)306,114
Market cap$1.6B
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)-6.63%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)-3.00%
P/E ratioNM
Price/Sales2.53
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
PENPenumbra Inc+0.11+0.20%
ICUIICU Medical Inc-1.62-1.60%
PODDInsulet Corp-0.16-0.48%
HYHHalyard Health Inc-3.34-10.60%
Data as of 04/29/2016

Financials

Last reporting dateMay 2, 2016
EPS forecast (this quarter)$0.46
Annual revenue (last year)$910.4M
Annual profit (last year)$16.9M
Net profit margin1.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Ronald G. Gelbman
Chief Operating Officer
Kent J. Davies
Corporate headquarters
Braintree, Massachusetts

Forecasts

Partner Offers

Search for Jobs